> LabCorp ($LH) rolled out its companion diagnostic test for determining which patients with non-small cell lung cancer are a good fit for treatment with Merck's ($MRK) Keytruda (pembrolizumab). Release
> Qiagen ($QGEN) launched new bioinformatics tool for hereditary disease testing at the American Society for Human Genetics (ASHG) annual meeting in Baltimore. More
> Sweden's Immunovia is teaming up with the Knight Cancer Institute at Oregon Health & Science University to develop a blood test for the early diagnosis of pancreatic cancer. Statement
> San Diego-based bioTheranostics is joining forces with DeNovo Sciences to see how well its cancer biomarkers would work in liquid biopsy tests. Release
And Finally… Roche ($RHHBY) cut the ribbon on a new diagnostics training lab in the U.K. Story